TITLE

Bromocriptine in Parkinsonism

AUTHOR(S)
Calne, D. B.; Teychenne, P. F.; Claveria, L. E.; Eastman, R.; Greenacre, J. K.; Petrie, A.
PUB. DATE
November 1974
SOURCE
British Medical Journal;11/23/1974, Vol. 4 Issue 5942, p442
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64322235

 

Related Articles

  • Galactorrhoea after withdrawal of bromocriptine. Pentland, B.; Sawers, J.S.A. // British Medical Journal;9/13/1980, Vol. 281 Issue 6242, p716 

    Describes the galactorrhea after withdrawal of bromocriptine in patient with parkinsonism. Secretion of prolactin from the anterior pituitary by bromocriptine; Restoration of serum prolactin concentrations to pretreatment values after withdrawal of bromocriptine in patients with...

  • Lactation suppression and bromocriptine.  // American Family Physician;12/1/1994, Vol. 50 Issue 8, p1831 

    Cites the US Food and Drug Administration's (FDA) announcement that bromocriptine (Parlodel) is no longer indicated for the prevention of physiologic lactation. Adverse reactions; Use of bromocriptine for the treatment of Parkinson's disease, acromegaly and dysfunction associated with...

  • Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Lees, A.J. // BMJ: British Medical Journal (International Edition);8/21/93, Vol. 307 Issue 6902, p469 

    Compares the therapeutic effects of levodopa, selegiline and bromocriptine for the treatment of Parkinson's disease in Great Britain. Baseline characteristics of the three drugs; Adverse reactions of levodopa and selegiline; Therapeutic response of bromocriptine.

  • Bromocriptine induced impotence in Parkinson's disease. Cleeves, Lynn; Findley, Leslie J. // British Medical Journal (Clinical Research Edition);8/8/1987, Vol. 295 Issue 6594, p367 

    Examines the bromocriptine induced impotence in patients with Parkinson's diseases. Increased sexual drive in patients with Parkinson's disease; Association of hypersexual behavior with an acute brain syndrome; Common feature of Parkinson's disease.

  • Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease : A short commentary. Quinn, N. P. // Journal of Neurology;Jan2003, Vol. 250 Issue 1, p97 

    Comments on ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease. Effect of dopamine agonists on Parkinson's disease patients on chronic levodopa therapy; Equivalence between adjunctive ropinirole and bromocriptine.

  • Comparison of treatments for early Parkinson's disease.  // American Family Physician;1/1/1994, Vol. 49 Issue 1, p206 

    Reports on the comparison of treatments for early Parkinson's disease as studied by the Parkinson's Disease Research Group of the United Kingdom and published in the August 21, 1993 issue of the `British Medical Journal.' Principal therapeutic alternatives; Use of levodopa and bromocriptine.

  • Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine. Martina Fantin; Matteo Marti; Markus Drechsler; Lydia Paccamiccio; Paolo Mariani; Elisa Sivieri; Francesco Lain; Enea Menegatti; Michele Morari; Rita Cortesi // Pharmaceutical Research;Jul2008, Vol. 25 Issue 7, p1521 

    Abstract Purpose  The present investigation describes a formulative study for the development of innovative drug delivery systems for bromocriptine. Methods  Solid lipid nanoparticles (SLN) based on different lipidic components have been produced and characterized. Morphology and...

  • Solid Lipid Nanoparticles as Delivery Systems for Bromocriptine. Martina Fantin; Matteo Marti; Markus Drechsler; Lydia Paccamiccio; Paolo Mariani; Elisa Sivieri; Francesco Lain; Enea Menegatti; Michele Morari; Rita Cortesi // Pharmaceutical Research;Jul2008, Vol. 25 Issue 7, p1521 

    Abstract Purpose  The present investigation describes a formulative study for the development of innovative drug delivery systems for bromocriptine. Methods  Solid lipid nanoparticles (SLN) based on different lipidic components have been produced and characterized. Morphology and...

  • bromocriptine. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p128 

    An encyclopedia entry for "bromocriptine" is presented. It refers to an agent utilized to hinder the production of prolactin for treating diseases like noncancerous pituitary tumours. This drug may also be utilized to inhibit the production of milk after childbirth and to cure Parkinson's...

  • Which drugs work best for early Parkinson's disease? Jam, Liza; Benko, Rebecca; Safranek, Sarah // Journal of Family Practice;Feb2012, Vol. 61 Issue 2, p106 

    The article discusses two medications in treating early Parkinson's disease. It mentions the use of Levodopa/carbidopa as medication for Parkinson's disease, but may result on the occurrence of dyskinesia and dystonia. It also cites the use of bromocriptine, a dopamine agonist for treating...

Share

Read the Article

Other Topics